Press "Enter" to skip to content

BioNTech Covid-19 increases vaccine production capacity to 2.5 billion doses – Health News

While vaccination studies are continuing within the scope of combating corona virus worldwide, German biotechnology company and corona virus vaccine manufacturer BioNTech updated its vaccine production target.

In the statement made by the company, it was announced that after the commissioning of a new facility with the US pharmaceutical giant Pfizer, the Covid-19 vaccine production capacity is expected to be increased to 2.5 billion doses by the end of 2021.

“Additional measures and negotiations are underway with potential partners to further expand the production capacity and network,” the statement said.

Pfizer previously announced that they could produce an estimated 2.3 billion to 2.4 billion doses of vaccine this year.


Download the NTV application, be informed about the developments

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *